Erythromycin or clindamycin - is it still an empirical therapy against Streptococcus agalactiae in patients allergic to Penicillin?

• Autorzy: Leszczynski P. , Sokol-Leszczynska B. , Pietrzak B. , Sawiacka-Grzelak A. , Wielgos M.
• Języki publikacji: EN

Abstrakty

EN

Retrospective analysis of Streptococcus agalactiae antibiotic susceptibility isolated in 2010–2013 was performed. Penicillin was still the first-line antibiotic. Due to the high percentage of strains resistant to erythromycin and clindamycin empirical treatment with these antibiotics may not be effective. Lower resistance rate to erythromycin and clindamycin among strains isolated from infected pregnant women and newborns were observed than among strains isolated from samples from patients hospitalized in other departments (29% and 47% v. 46% and 63%). The increasing resistance rate might give a rise to a new epidemiological situation.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2017
• Tom: 66
• Numer: 2
• Opis fizyczny: p.265-268,ref.

Twórcy

autor

Leszczynski P.

• Department of Medical Microbiology, Warsaw Medical University of Warsaw, Warsaw, Poland
• Hospital Infection Control Team, Infant Jesus University Hospital, Warsaw, Poland

autor

Sokol-Leszczynska B.

• Department of Medical Microbiology, Warsaw Medical University of Warsaw, Warsaw, Poland
• Department of Medical Microbiology, Infant Jesus University Hospital, Warsaw, Poland

autor

Pietrzak B.

• First Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland

autor

Sawiacka-Grzelak A.

• Department of Medical Microbiology, Warsaw Medical University of Warsaw, Warsaw, Poland
• Department of Medical Microbiology, Infant Jesus University Hospital, Warsaw, Poland

autor

Wielgos M.

• First Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland

Bibliografia

• Abdelazim I.A. 2013. Intrapartum polymerase chain reaction for detection of group B Streptococcus colonisation. Aust. NZJ Obstet. Gynaecol. 53(3): 236–242.
• Arana D.M., B.R. Bezares and C.T. Manrique. 2014. First clinical isolate in Europe of clindamycin-resistant group B Streptococcus mediated by the lnu (B) gene. Rev. Esp. Qui 27(2): 106–109.
• Bigos M., M. Łysakowska and M. Wasiela. 2012. Perinatal infec-tions of etiology Streptococcus agalactiae (in Polish). Post. Mikrobiol. 51(4): 299–308.
• Brown H.L., H.K. Ahmadzia and R.P. Heine. 2013. GBS Screen-ing: An update on guidelines and methods. http://contemporar-yobgyn.modernmedicine.com/contemporary-obgyn/content/tags/bd-geneohm/gbs-screening-update-guidelines-and-methods, 2016.04.18.
• Church D.L., H. Baxter and T. Lloyd. 2011. Evaluation of the Xpert group B Streptococcus real-time polymerase chain reaction assay compared to StrepB Carrot Broth for the rapid intrapartum detec-tion of group B streptococcus colonization. Diagn. Microbiol. Infect. Dis. 69: 460–462.
• Clifford V., H.M. Heffernan and K. Grimwood. 2011. Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B Streptococcus isolates. NZJ Obstet. Gynaecol. 1(4): 328–332.
• de-Paris F., A.B.M.P. Machado and T.C. Gheno. 2011. Group BStreptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. Braz. J. Infect. Dis. 15(4): 323–327.
• Di Renzo G.C., P. Melin and A. Berardi. 2015. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus confer-ence. J. Matern. Fetal. Neonatal. Med. 28(7): 766–778.
• Edwards R.K., P. Clark and P. Duff. 2002. Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B strepto-coccicultures and antibiotic susceptibility of clinical isolates. Obstet. Gynecol. 100: 540–544.
• Helali N.E., Y. Giovangrandi and K. Guyot. 2012. Cost and effec-tiveness of intrapartum group B Streptococcus polymerase chain reaction screening for term deliveries. Obstet. Gynecol. 119: 822–829.
• Kasahara K., A.K. Baltus and S.H. Lee. 2010. Prevalence of non-penicillin-susceptible group B Streptococcus in Philadelphia and specificity of penicillin resistance screening methods. J. Clin. Microb.48 (4): 1468–1469.
• National Institute for Health and Care Excellence. 2015. Xpert GBS test for the intrapartum detection of group B Streptococcushttps://www.nice.org.uk/advice/mib28/resources/xpert-gbs-test-for-the-intrapartum-detection-of-group-b-streptococcus- 63499051847365, 2016.04.18.
• Poncelet-Jasserand E., F. Forges and M.N. Varlet. 2013. Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR a ss ay. BJOG 120: 1098–1108.
• Savini V., R. Marrollo and M. D’Antonio. 2013. Case Report. Strep-tococcus agalactiae vaginitis: nonhemolytic variant on the LiofilchemChromatic StreptoB. Int. J. Clin. Exp. Pathol. 6(8): 1693–1695.
• Seo Y.S., U. Srinivasan and K.Y. Oh. 2010. Changing molecular epidemiology of group B Streptococcus in Korea. J. Korean Med. Sci. 25: 817–823.
• Srinivasan V., B.J. Metcalf and K.M. Knipe. 2014. Van G element insertions within a conserved chromosomal site conferring van-comycin resistance to Streptococcus agalactiae and Streptococcus anginosus. mBio 5(4): e01386–14.
• Szymusik I., K. Kosińska-Kaczyńska and B .Pietrzak. 2014. Is it time for a change in screening for GBS carriage? (in Polish). Ginekol. Pol. 85: 456–460.
• Verani J.R., L. McGee and S.J. Schrag. 2010. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010.MMWR 59(RR10): 1–32.
• Verani J.R. and S.J. Schrag. 2010. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin. Perinat. 37: 375–392.

Identyfikatory

DOI

10.5604/01.3001.0010.7878